journal article text

Supplementary Figure 2 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Abstract

Dasatinib in combination with cisplatin in resistant TC cells</p

    Similar works

    Full text

    thumbnail-image